Background--Atherosclerosis is an inflammatory lipid disorder and the main underlying pathology of acute ischemic events. Despite a vast amount of data from murine atherosclerosis models, evidence of B-cell involvement in human atherosclerotic disease is limited. We therefore investigated the association of circulating B-cell subtypes with the occurrence of secondary cardiovascular events in advanced atherosclerotic disease.
A lthough the prevention of cardiovascular disease (CVD) has improved in the past decades, it remains one of the major causes of death worldwide. 1 Its main underlying pathology, atherosclerosis, is an inflammatory lipid disorder and the major cause of acute cardiovascular syndromes. [2] [3] [4] Many inflammatory cell types, including monocytes, macrophages, mast cells, neutrophils, and T and B cells, have been implicated in the initiation, progression, and destabilization of atherosclerosis. 5 Increased insights into how these inflammatory cells are involved in CVD may lead to the identification of novel biomarkers or therapeutic targets for primary or secondary manifestations of CVD. The risk of cardiovascular events is particularly high in patients with earlier CVD manifestations. 6, 7 For example, the 3-year cumulative incidence of major adverse cardiovascular events in patients undergoing carotid endarterectomy was 13%. 8 Increased inflammation is an important risk factor for recurrent CVD events. 2 For example, different studies showed that high white blood cell counts are associated with the recurrence of CVD events and mortality. [9] [10] [11] [12] [13] These studies, however, mainly consider total white blood cell count or total lymphocyte counts and do not provide additional information regarding cell-specific subtypes.
Besides their well-known role in humoral immunity through antibody production, B cells are important for T-cell activation and cytokine production in maintaining immune homeostasis. 14 The total peripheral B-cell pool in humans mainly consists of na€ ıve B cells, CD43 + B1-like cells, [15] [16] [17] 18 or IgG and IgA antibodies, respectively 18 ), regulatory B cells, and plasma cells. As such, B cells are important in immune homeostasis, but have also been shown to be detrimental in autoimmune diseases like common variable immunodeficiency and systemic lupus erythematosus. 19, 20 Interestingly, patients with these B-cell-driven autoimmune diseases are also at high risk for CVD. 19, 20 Evidence for an important role of B lymphocytes in human CVD is limited. In patients with acute myocardial infarction (MI), high levels of the B-cell specific cytokines, chemokine (C-C motif) ligand 7 and B-cell activating factor, predict increased risk of death and recurrent MI. 21 In addition, hypertensive patients with high percentages of CD40 + B cells were at lower risk for stroke, 22 whereas high numbers of CD86 + B cells showed higher risk for stroke. 22 A larger body of evidence is derived from elaborate mouse studies, which identified a subset-specific role for B lymphocytes in atherosclerosis. [23] [24] [25] To date, it is generally accepted that (auto)antibody-producing B1 B cells are atheroprotective 26, 27 and this protective effect depends on IgM secretion, 28 whereas conventional B2 B cells are generally considered proatherogenic. 29 This proatherogenic phenotype in mice has mainly been attributed to the production of pathogenic IgG antibodies against oxidized lowdensity lipoprotein (oxLDL) and the immune effector function of these B cells. 27, 28, [30] [31] [32] [33] In human atherosclerosis, however, there is conflicting evidence about the role of autoantibodies directed against oxLDL. On the one hand, oxLDL antibodies have been associated with the presence 34 and progression [35] [36] [37] of atherosclerosis and the risk for MI. On the other hand, antioxLDL autoantibodies have also been associated with lower oxLDL levels 38 and decreased carotid atherosclerosis as well.
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In addition, vaccination with a pneumococcal vaccine, mimicking oxLDL epitopes, was shown to attenuate atherosclerotic lesion formation in mice 40 and, according to a recent metaanalysis, also prevents CVD in adults. 41 Taken together, accumulating evidence points to an important role of B cells in CVD, but human evidence is limited. In order to establish whether a specific B-cell profile is associated with secondary cardiovascular events, we measured circulating B-cell subtypes, including na€ ıve, CD43 + B1-like, unswitched, and switched memory B cells, as well as oxLDL antibodies, in severe atherosclerotic patients derived from the Athero-Express biobank. B-cell subtypes were identified by flow cytometry and associated with the occurrence of secondary cardiovascular manifestations during follow-up after carotid endarterectomy.
Materials and Methods

Study Population
This study includes a subcohort of 168 patients from the Athero-Express biobank, a cohort study of patients undergoing carotid endarterectomy that were included between 2009 and 2011. 42 In addition to the standard procedure, including an extensive patient questionnaire and detailed histological plaque characterization, peripheral blood mononuclear cells (PBMCs) were isolated from blood that was drawn preoperatively. Isolated PBMCs were stored in liquid nitrogen until further analyses were performed. Patient follow-up duration was 3 years or until the occurrence of secondary cardiovascular events (cardiovascular death, stroke, MI, coronary intervention, peripheral intervention [including amputation], or a combination). All events were validated using health records kept by general practitioners. All patients provided written informed consent. The study protocol conforms to the Declaration of Helsinki and has been approved by the Institution's ethics committee on research on humans. Figure 1 ). Absolute B-cell numbers were calculated from the ratio measured by flow cytometry multiplied by the absolute number of lymphocytes obtained from the hematology cell counter.
Blood Collection and PBMC Isolation
Anti-oxLDL Antibody Measurements
Serum levels of IgM and IgG-a-oxLDL antibodies were measured as described previously. 40, 43 In short, serum samples were diluted 500 times for IgM and 2000 times for IgG-a-oxLDL antibody measurements. Antibody titers were determined by chemiluminescent enzyme immunoassays, and values are presented as relative light units per 100 ms.
Statistical Analysis
Normally distributed continuous variables are indicated as meansAESDs and compared by Student's t tests or a 1-way ANOVA. Non-normal distributed data are presented as medians (interquartile ranges; IQRs) and were compared by Kruskal-Wallis tests. Categorical variables were indicated as percentages and compared by chi-square or Fisher's exact tests where appropriate. As confounders, we selected variables that associate with CVD risk, but also influence Bcell numbers and have been established as confounders in literature, including age, sex, smoking, history of coronary artery disease, and glomerular filtration rate. 22, [44] [45] [46] [47] We also tested for a sex interaction between the association of B cells and cardiovascular end points. Univariable and multivariable Cox proportional hazard models were used to study the association of B-cell subtypes and anti-oxLDL antibodies with occurrence of secondary cardiovascular events over time. Next, to visualize this association, subjects were divided into tertiles according to the absolute numbers of B-cell subtypes and plotted against the occurrence of secondary cardiovascular events over time. Data management and statistical analyses were performed with RStudio 48 
Results
Clinical Characteristics
Baseline characteristics are shown in Table 2 , stratified into patients with and without secondary cardiovascular events. Of the included 168 patients, 54 experienced secondary cardiovascular events during follow-up, which included cardiovascular death (n=11), stroke (n=13), coronary events (n=11), and peripheral intervention (n=35). Risk factors for the presence of CVD, such as age, sex, smoking, and kidney function (glomerular filtration rate), did not differ between patients with or without secondary events (Table 2) .
Total B Cells and (Un)Switched Memory B Cells Are Higher in Patients Without Secondary Cardiovascular Events
We measured different B-cell subtypes using flow cytometry. Total B cell numbers (%200 cells/lL) and B-cell subset numbers corroborate with earlier observations 50 ( Table 3) .
Next, we investigated whether baseline levels of B cells differed between patients who developed secondary cardiovascular events during follow-up after endarterectomy (cases) compared to those without a secondary event (controls; cells also tended to be higher, these differences were not statistically significant between groups. Baseline characteristics of patients stratified by B lymphocyte tertiles are shown in Table 4 .
Associations of B-cell subtypes with univariate risk factors
We then investigated whether the numbers of B cells or B-cell subtypes were associated with cardiovascular risk factors. As expected, total B-cell numbers decreased with age and were higher in women and in current smokers. Specific associations of each B-cell subtype with the cardiovascular risk factors are depicted in Table 5 . We selected age, sex, smoking, history of coronary artery disease, and glomerular filtration rate as potential confounders, based on their established prognostic value in CVD.
Cox regression analysis of B cells with secondary cardiovascular events
Because of the known B-cell-related immunological differences between sexes, we tested sex interaction between the association of B cells and cardiovascular end points, but there was no statistically significant interaction. Univariable and multivariable Cox proportional hazard regression models were used to calculate the hazard ratios (HRs) for each B-cell subset (Table 6 ). Patients were then categorized into tertiles according to the absolute number of B cells and B-cell subsets. Interestingly, patients with high numbers of unswitched memory B cells were at lower risk of experiencing a secondary cardiovascular event during follow-up as compared with patients with low numbers (HR, 0.30 [95% confidence interval (CI), 0.13-0.69]; P<0.01; Figure 2 ). Likewise, patients in the highest tertile of switched memory cell numbers were at lower risk than patients in the lowest tertile (HR, 0.33 [95% CI, 0.14-0.77]; P=0.01). When we combined 
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The associations between risk factors and B cell numbers are presented as beta [95% confidence intervals (CIs)]. For categorical variables, beta is the difference in B-cell numbers (cells/lL) between groups. For continuous variables, beta is the linear regression coefficient relating a 1-unit increase in the variable to the associated change in B-cell numbers.
"P Value" is the P value of the linear or logistic regression model for association. BMI indicates body mass index; CAD history, history of Coronary Artery Disease; Contralateral stenosis, 50% to 100% stenosis of the contralateral carotid artery; GFR MDRD, Glomerular filtration rate according to Modification of Diet in Renal Disease formula; HDL, high-density lipoprotein; hsCRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein.
both the numbers of switched and unswitched memory cells, patients in the highest tertile of total memory cells were still at lower risk (HR, 0.35 [95% CI, 0.15-0.83]; P=0.02) compared with patients in the lowest tertile of total memory cells; however, the combination did not further decrease the risk for recurrent CVD events as the HR was comparable.
Comparable results were obtained when we excluded secondary surgical interventions from the composite end point (25 end points remaining). In multivariable Cox proportional hazard regression models, patients in the highest tertile were at lower risk of events, now only consisting of cardiovascular death, stroke, or MI, as compared with patients in the lowest tertile (HR, 0. 
Surface IgM Expression Is Higher in Patients With High Numbers of Unswitched Memory Cells
IgM has been shown to be atheroprotective in mouse atherosclerosis models. To assess whether the protective effect of the (un)switched memory B cells is reflected by high expression of IgM, we measured surface expression of IgM. 
Discussion
We investigated the association of circulating B-cell subsets with the occurrence of secondary cardiovascular events in severe carotid atherosclerotic patients undergoing carotid endarterectomy. We found that high levels of (un)switched memory cells were independently associated with the freedom of recurrent cardiovascular events, suggesting that patients with high numbers of (un)switched B cells are protected against secondary cardiovascular manifestations. Patients with autoimmune diseases, such as systemic lupus erythematosus and common variable immunodeficiency, have an increased risk of developing CVD. Production of (auto) antibodies by B lymphocytes is a hallmark of autoimmune disease and autoantibody formation is also evident in atherosclerotic patients. SLE patients have reduced levels of both switched and unswitched memory cells, 19 and decreased levels of unswitched memory cells are associated with increased levels of SLE autoantibodies. 19 Furthermore, in patients with common variable immunodeficiency, levels of switched memory cells are lower compared with controls. 20 As such low levels of switched and unswitched memory B cells are associated with an unfavorable inflammatory status and, as we show here for the first time, with secondary cardiovascular events in patients with severe atherosclerosis. Similar to our observations regarding the memory B cells, it has previously been shown that patients with high CD40 + B-cell percentages exhibit a lower stroke risk. 22 Accordingly, we also observed a lower rate of cerebrovascular events in patients with high memory cell numbers (0.6%) compared with patients with low numbers (3.6%). However, because of the low prevalence of cerebrovascular events within our population, we were not sufficiently powered to confirm these findings statistically.
The role of IgM antibodies in CVD has gained much attention in the last decades. In mouse models, it was shown that IgM secreted by B1 B cells was responsible for their atheroprotective effect. 28 In contrast to their role in mouse studies, 28, 33 CD43 + B cells, suggested to resemble B1 cells in mice, 15 did not associate with protection against secondary events in our study. Contrasting results have been reported for the association of serum IgM levels with primary cardiovascular events. [51] [52] [53] In our study, patients with high numbers of unswitched memory cells expressed more IgM on their cell surface, suggesting an increased production and release of IgM antibodies. However, it remains to be elucidated whether the increase of surface IgM expression translates to higher circulating IgM antibody levels and to which antigens this IgM is directed. To investigate whether the protective effect of memory B cells involves autoantibodies directed against oxLDL, we measured oxLDL-specific titers of IgM and IgG. IgM-a-oxLDL antibody titers were not different between patients with and without a follow-up event, nor were they associated with the number of unswitched memory B cells. The number of class switched memory cells did show significant correlations with serum IgG-a-oxLDL antibody titers, indicating that the switched memory cells might indeed be responsible for the production of IgG-a-oxLDL antibodies. However, IgG-a-oxLDL titers were not associated with the occurrence of secondary CVD events, suggesting that oxLDL antibodies are not responsible for the protective effect of memory B cells in our population of severe atherosclerotic patients. These data are in line with other observations that also show no association with secondary CVD events, 54,55 but do not corroborate with other studies showing oxLDL antibodies to be associated with occurrence and severity of CVD. [34] [35] [36] [37] Apart from their pivotal role in antibody generation, B cells can also regulate T-cell responses and produce cytokines, suggesting a more-intricate role in cardiovascular disease. 14, 56 In conclusion, we show that high numbers of unswitched and switched memory B cells are associated with lower risk of secondary cardiovascular events in a population with severe CVD. These findings are based on a relatively small patient cohort and should be established in larger patient cohorts. However, our findings do suggest a potential role for B-cell subsets in prediction and prevention of secondary cardiovascular events in patients with atherosclerosis. 
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